Ethnic considerations in pharmacogenetic studies

被引：3

作者：

Branford, Ruth A. ^{[1
,2
]}

Pantelidis, Panagiotis ^{[2
]}

Ross, Joy R. ^{[1
,2
]}

机构：

[1] St Josephs Hospice, London, England

[2] Univ London Imperial Coll Sci Technol & Med, Interstitial Lung Dis Unit, Dept Populat Genet & Gene Therapy, Natl Heart & Lung Inst, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 10期

关键词：

D O I：

10.1200/JCO.2007.15.5929

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1766 / 1767

页数：3

共 3 条

[1] mdr-1 single nucleotide polymorphisms in ovarian cancer tissue:: G2677T/A correlates with response to paclitaxel chemotherapy [J].

Gréen, H ;

Söderkvist, P ;

Rosenberg, P ;

Horvath, G ;

Peterson, C .

CLINICAL CANCER RESEARCH, 2006, 12 (03) :854-859

[2] Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: The Scottish randomised trial in ovarian cancer [J].

Marsh, Sharon ;

Paul, Jim ;

King, Cristi R. ;

Gifford, Gillian ;

McLeod, Howard L. ;

Brown, Robert .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) :4528-4535

[3] Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma [J].

Vasey, PA ;

Jayson, GC ;

Gordon, A ;

Gabra, H ;

Coleman, R ;

Atkinson, R ;

Parkin, D ;

Paul, J ;

Hay, A ;

Kaye, SB .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (22) :1682-1691

← 1 →